Skip to main content

Table 2 Information of studies included in the analysis step. Initial mean weight (kg), Mean weight change (kg) and Final mean weight (kg)

From: RETRACTED ARTICLE: The best drug supplement for obesity treatment: a systematic review and network meta-analysis

Row

First author

Publication year

Supplement type

Initial mean weight (kg)

Mean weight change (kg)

Final mean weight (kg)

P-value

1

Apovian [25]

2013

Placebo

99.2 ± 15.9

− 1.5 ± 0.5

97.7 ± 15

 < 0.001

Naltrexone + bupropion

100.3 ± 16.6

− 7.9 ± 0.3

92.4 ± 11

2

Aronne [26]

2010

Placebo

107 ± 22

− 2.1 ± 0.9

104.9 ± 21

 < 0.05

Pramlintide

102 ± 19

− 3.6 ± 0.7

98.4 ± 18.5

3

Davies [27]

2015

Placebo

106.5 ± 21.3

− 2.2

104.3 ± 20

 < 0.001

Liraglutide 0.3 mg

105.7 ± 21.9

− 6.4

99.3 ± 18.9

Liraglutide 1.8 mg

105.8 ± 21

− 5

100.8 ± 19

4

Fidler [28]

2011

Placebo

100.8 ± 16.2

− 2.9 ± 6.4

97.9 ± 15

 < 0.001

Lorcaserin 10 mg BID

100.3 ± 15.7

− 5.8 ± 6.4

94.5 ± 12

Lorcaserin 10 mg QD

100.1 ± 16.7

− 4.7 ± 6.4

95.4 ± 13.5

5

Gadde [29]

2011

Placebo

103.3 ± 18.1

− 1.4

101.9 ± 17.5

 < 0.0001

Phentermine 7.5 mg + topiramate 46.0 mg

102.6 ± 18.2

− 8.1

94.5 ± 15.5

Phentermine 15.0 mg + topiramate 92.0 mg

103 ± 17.6

− 10.2

92.8 ± 10.6

6

Greenway [30]

2010

Placebo

99.5 ± 14.3

− 1.9 ± 0.5

97.6 ± 14

 < 0.0001

Naltrexone + bupropion 16.0 mg

99.5 ± 14.8

− 6.5 ± 0.5

93 ± 11.5

Naltrexone + bupropion 32.0 mg

99.7 ± 15.9

− 8 ± 0.5

91.7 ± 12

7

le Roux [31]

2017

Placebo

107.9 ± 21.8

− 2 ± 7.3

105.9 ± 21

 < 0.0001

Liraglutide

107.5 ± 21.6

− 6.5 ± 8.1

101 ± 18

8

Lu [32]

2018

Placebo

91.5 ± 14.5

− 3.6

87.9 ± 13

0.044

Lorcaserin

92.6 ± 13.3

− 5.8

86.8 ± 10

9

O’neil [33]

2012

Placebo

101.6 ± 18.1

 

101.7 ± 18.3

 

Orlistat 120.0 mg BID

104.7 ± 17.9

 

104.7 ± 17.9

 

Orlistat 120.0 mg QD

105.9 ± 19.0

 

105.4 ± 19.2

 

10

Pi-Sunyer [34]

2015

Placebo

106.2 ± 21.7

− 2.8 ± 6.5

103.4 ± 20

 < 0.001

Liraglutide

106.2 ± 21.2

− 8.4 ± 7.3

97.8 ± 17

11

Smith [35]

2010

Placebo

99.7 ± 0.4

− 2.2 ± 0.1

97.5 ± 0.4

 < 0.001

Lorcaserin

100.4 ± 0.4

− 5.8 ± 0.2

94.6 ± 0.4